Skip to content
bioinnovationbeacon.com

bioinnovationbeacon.com

  • Home
  • AI
  • Biotech News
  • Research
  • Technology
  • Press Releases
  • Privacy Policy
  • Contact Us

Trading by management and close relations of management

November 19, 2026byadmin
trading-by-management-and-close-relations-of-management

Please read the announcement in PDF

Attachment

  • 2026_30_Trading_By_Management

Globenewswire

Post navigation

Medicus Pharma Regains Compliance with Nasdaq Minimum Equity Requirement for Continued Listing
Actinogen pivotal Alzheimer’s disease trial demonstrates clinical benefit in older patients with mild to moderate disease, favorable safety profile and trends towards benefit in the overall population

Related Posts

humacyte-innovative-research-in-coronary-bypass-and-vascular-regeneration-to-be-highlighted-at-american-heart-association-scientific-sessions-2026
Humacyte Innovative Research in Coronary Bypass and Vascular Regeneration to be Highlighted at American Heart Association Scientific Sessions 2026

– Founder & CEO Laura Niklason, M.D., Ph.D., to deliver invited talk on engineering the microenvironment to accelerate vascular regeneration.…

genfit-presente-les-donnees-issues-des-etudes-cliniques-de-nangibotide-soutenant-la-poursuite-de-son-developpement-dans-l’aclf.-resultats-de-phase-2-attendus-en-2027
GENFIT présente les données issues des études cliniques de nangibotide soutenant la poursuite de son développement dans l’ACLF. Résultats de phase 2 attendus en 2027

Un ensemble complet de données cliniques et scientifiques solides soutenant le développement de Phase 2 de nangibotide dans l’ACLF présenté…

taysha-gene-therapies-reports-third-quarter-2026-financial-results-and-provides-corporate-update
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update

REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report topline data from 6-month interim analysis…

| Depth News by Ascendoor | Powered by WordPress.